---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-010462"
form_type: "8-K"
ticker: "ALUR"
cik: "0001964979"
company_name: "ALLURION TECHNOLOGIES, INC."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:58:04.181238+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Allurion Q4 revenue up 22-37% QoQ; FY2025 revenue ~$15M

## Summary
- Q4 2025 revenue $3.3-3.7M (22-37% QoQ increase); full-year revenue ~$15M.
- Substantial QoQ and YoY improvement in operating expenses and operating loss.
- CEO cites strategic pivot taking hold; potential FDA approval of Allurion Smart Capsule in 2026.

## SEC filing metadata
- accession: 0001193125-26-010462
- form_type: 8-K
- ticker: ALUR
- cik: 0001964979
- company_name: ALLURION TECHNOLOGIES, INC.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964979/000119312526010462/0001193125-26-010462-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964979/000119312526010462/alur-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-010462
- JSON: https://secwatch.observer/filing/0001193125-26-010462.json
- Plain text: https://secwatch.observer/filing/0001193125-26-010462.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.